Biopharma Marketing Outlook for 2025

Download the report ↗️Ask GenAI for help

Our latest report explores the key trends driving biopharma marketing, including:

  • How modular platforms can unify digital efforts and enhance commercial execution

  • The power of direct-to-stakeholder strategies in elevating HCP and patient engagement

  • AI’s role in delivering fast, personalized content while ensuring global compliance

About the authors

Digitalya is a top-quality web app development company that drives digital transformation for life sciences companies. With more than 60 successful projects worldwide and extensive experience working with the top 10 global pharmaceutical enterprises, our goal is to help innovators by building custom HCP and patient portals, GenAI solutions, engagement tools, and digital companions.

Contact us

Magnolia gives enterprises a digital experience platform (DXP) that’s made for theirreal-world needs. It enables biopharma companies to unify their commercial digitalecosystem, create and globally distribute compliant content faster and easier, anddeliver seamless, personalized HCP and patient experiences across brands, sites,and channels.

Learn how Magnolia provides the digital foundation for commercial execution.

Contact Magnolia